human isogenic cell lines

NEW YORK (GenomeWeb News) – Horizon Discovery announced today a research service agreement to deploy its X-MAN isogenic cell lines in support of Blueprint Medicine's "New Targets" discovery platform.

NEW YORK (GenomeWeb News) – Horizon Discovery said today it has entered into a research collaboration covering gene editing with the Institute of Neurology, University College London.

NEW YORK (GenomeWeb News) – Crown Bioscience and Horizon Discovery today announced that they will partner on offering new in vivo X-MAN models as a service to Crown's customers.

NEW YORK (GenomeWeb News) – Horizon Discovery today said that it has established a Center of Excellence at Washington University in St. Louis.

NEW YORK (GenomeWeb News) – Horizon Discover today said it has signed a licensing and distribution deal with the American Type Culture Collection for certain sets of panels of X-Man isogenic cell lines.

NEW YORK (GenomeWeb News) – Horizon Discovery today announced it has signed an agreement with Bayer Pharma for the use of Horizon's Genesis genome editing technology in support of Bayer's cancer R&D programs.

NEW YORK (GenomeWeb News) – Horizon Discovery and biopharmaceutical firm H3 Biomedicine today announced a collaboration to identify and validate a panel of novel cancer drug targets.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Horizon Discover today said it is collaborating with the Rosalind Franklin University of Medical Sciences to develop a human cellular disease model of cystic fibrosis.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Horizon Discovery today announced a collaboration with Promega to develop next-generation predictive human disease models.

Pages

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.